Back to MetLife Investment Management, LLC MetLife Investment Management, LLC

IMNMIMNM
9 quarters

Position history for MetLife Investment Management, LLCMetLife Investment Management, LLC's holdings in IMMUNOME INC

Yes. MetLife Investment Management holds 859,076 shares of IMNM (Immunome), worth $18.2M, as of its Q2 2026 13F filing. It increased the position from 55,857 shares in Q1 2026. MetLife Investment Management has held IMNM since Q2 2024, across 9 quarterly 13F filings. IMNM is 0.1% of MetLife Investment Management's reported 13F portfolio.

Current Value

$18.2M

Current Shares

859,076

Total Value Change

+$18M

Total Shares Change

+845,864

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
859,076
+1438.0%
$18.2M0.1%$21.19
46
2026-Q1
Increased
55,857
+7.3%
$1.2M0.0%$21.87
27
2025-Q4
Increased
52,034
+22.7%
$1.1M0.0%$21.48
30
2025-Q3
Unchanged
42,411
0.0%
$496,6330.0%$11.71
0
2025-Q2
Unchanged
42,411
0.0%
$394,4220.0%$9.30
0
2025-Q1
Increased
42,411
+19.1%
$285,4260.0%$6.73
28
2024-Q4
Increased
35,619
+17.7%
$378,2740.0%$10.62
28
2024-Q3
Increased
30,265
+129.1%
$442,4740.0%$14.62
39
2024-Q2
New
13,212
-
$159,8650.0%$12.10
31

Other major holders of IMNM: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used